Genovis AB (publ.) Statistics

Total Valuation

STO:GENO has a market cap or net worth of SEK 1.74 billion. The enterprise value is 1.64 billion.

Market Cap	1.74B
Enterprise Value	1.64B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:GENO has 65.47 million shares outstanding.

Current Share Class	65.47M
Shares Outstanding	65.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.73%
Owned by Institutions (%)	53.45%
Float	55.82M

Valuation Ratios

The trailing PE ratio is 73.83 and the forward PE ratio is 56.11. STO:GENO's PEG ratio is 1.44.

PE Ratio	73.83
Forward PE	56.11
PS Ratio	14.08
PB Ratio	7.50
P/TBV Ratio	7.78
P/FCF Ratio	60.33
P/OCF Ratio	58.79
PEG Ratio	1.44

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 48.26, with an EV/FCF ratio of 56.87.

EV / Earnings	69.61
EV / Sales	13.28
EV / EBITDA	48.26
EV / EBIT	68.95
EV / FCF	56.87

Financial Position

The company has a current ratio of 8.27, with a Debt / Equity ratio of 0.32.

Current Ratio	8.27
Quick Ratio	6.75
Debt / Equity	0.32
Debt / EBITDA	2.21
Debt / FCF	2.61
Interest Coverage	5.89

Financial Efficiency

Return on equity (ROE) is 10.80% and return on invested capital (ROIC) is 5.06%.

Return on Equity (ROE)	10.80%
Return on Assets (ROA)	4.73%
Return on Invested Capital (ROIC)	5.06%
Return on Capital Employed (ROCE)	7.88%
Revenue Per Employee	3.75M
Profits Per Employee	716,061
Employee Count	32
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

In the past 12 months, STO:GENO has paid 12.80 million in taxes.

Income Tax	12.80M
Effective Tax Rate	35.14%

Stock Price Statistics

The stock price has decreased by -12.50% in the last 52 weeks. The beta is 1.91, so STO:GENO's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	-12.50%
50-Day Moving Average	23.26
200-Day Moving Average	24.22
Relative Strength Index (RSI)	58.77
Average Volume (20 Days)	169,826

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:GENO had revenue of SEK 123.87 million and earned 23.63 million in profits. Earnings per share was 0.36.

Revenue	123.87M
Gross Profit	107.88M
Operating Income	23.97M
Pretax Income	36.43M
Net Income	23.63M
EBITDA	27.73M
EBIT	23.97M
Earnings Per Share (EPS)	0.36

Full Income Statement

Balance Sheet

The company has 175.41 million in cash and 75.56 million in debt, giving a net cash position of 99.86 million or 1.53 per share.

Cash & Cash Equivalents	175.41M
Total Debt	75.56M
Net Cash	99.86M
Net Cash Per Share	1.53
Equity (Book Value)	232.59M
Book Value Per Share	3.55
Working Capital	188.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.68 million and capital expenditures -758,000, giving a free cash flow of 28.92 million.

Operating Cash Flow	29.68M
Capital Expenditures	-758,000
Free Cash Flow	28.92M
FCF Per Share	0.44

Full Cash Flow Statement

Margins

Gross margin is 87.09%, with operating and profit margins of 19.35% and 19.08%.

Gross Margin	87.09%
Operating Margin	19.35%
Pretax Margin	29.41%
Profit Margin	19.08%
EBITDA Margin	22.39%
EBIT Margin	19.35%
FCF Margin	23.35%

Dividends & Yields

STO:GENO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.35%
FCF Yield	1.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 4, 2012
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	4